alfapump System
Sequana Medical NV · Decision date Feb 18, 2026
What did the FDA decide?
FDA records P230044/S003 as a supplement to PMA P230044, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 18, 2026.
FDA approval order statement
Approval for changes to the cleaning agent used during manufacturing and for a new component supplier.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Feb 18, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P230044/S003
- Regulatory pathway
- PMA supplement
- Applicant
- Sequana Medical NV
- Product code
- SDQ
- Decision code
- OK30
- Decision date
- Feb 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: alfapump System.
- Applicant
- Sequana Medical NV
- Product code
- SDQ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P230044/S002 · Related supplement
alfapump System
P230044/S003 received
Application receipt date recorded by FDA.
P230044/S003 · FDA decision
30-Day Notice
P230044/S004 · Related supplement
alfapump System
P230044/S005 · Related supplement
alfapump System
Timeline entries are records held by MedtechLedger for P230044. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230044
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
alfapump SystemP230044/S002 | Sequana Medical NV | PMA supplement | Dec 19, 2025 | FDA |
alfapump SystemP230044/S004 | Sequana Medical NV | PMA supplement | May 5, 2026 | FDA |
alfapump SystemP230044/S005 | Sequana Medical NV | PMA supplement | May 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sequana Medical NV
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Kortrijksesteweg 1112, Sint-Denijs-Westrem, 9051
Sources and methodology
- Original FDA record: P230044/S003
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

